Onconetix, Inc. Defined Benefit Plan, Plan Assets, Amount
Onconetix, Inc. (ONCO) had Defined Benefit Plan, Plan Assets, Amount of $757.60 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan
us-gaap:DefinedBenefitPlanFairValueOfPlanAssets · last filed 2026-03-13
- 2025-06-30: Defined Benefit Plan, Plan Assets, Amount $757.60K.
- 2025-03-31: Defined Benefit Plan, Plan Assets, Amount $2.28M.
- 2024-12-31: Defined Benefit Plan, Plan Assets, Amount $2.31M.
- 2023-12-31: Defined Benefit Plan, Plan Assets, Amount $1.74M.
| Period end | Defined Benefit Plan, Plan Assets, Amount |
|---|---|
| 2025-06-30 | $757.60K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.28M 10-Q · filed 2025-06-12 |
| 2024-12-31 | $2.31M 10-K · filed 2026-03-13 |
| 2023-12-31 | $1.74M 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |